SCIENCE OF
POSSIBILITY
At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases.
The U.S. FDA has approved our newest treatment for cystic fibrosis
Vertex receives FDA approval for a label expansion for eligible patients with certain rare cystic fibrosis mutations
Vertex announces results from the Phase 2 study of our investigational pain treatment for people with painful lumbosacral radiculopathy
We announced new data on our CRISPR/Cas9 gene-edited treatment at the 2024 American Society of Hematology Annual Meeting
We report third quarter 2024 financial results
Working at Vertex
Our company is built on an inclusive culture that brings together the best and brightest in every field striving for one goal: to improve the lives of people with serious diseases.
Find a Vertex clinical trial
Volunteers who participate in clinical trials
help make new medicines a reality.
Featured stories